Group One Trading
PYXS icon

Group One Trading’s Pyxis Oncology PYXS Stock Holding History

Group One Trading’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.1K Sell
35,700
-132,500
-79% -$200K ﹤0.01% 5231
2025
Q4 		$193K Buy
168,200
+50,300
+43% +$177K ﹤0.01% 4400
2025
Q3 		$262K Buy
117,900
+103,700
+730% +$149K ﹤0.01% 4383
2025
Q2 		$15.6K Sell
14,200
-600
-4% -$676 ﹤0.01% 6432
2025
Q1 		$14.5K Sell
14,800
-85,400
-85% -$114K ﹤0.01% 6026
2024
Q4 		$156K Buy
+100,200
New +$289K ﹤0.01% 4130
2024
Q2 		– Sell
-20,100
Closed -$85.6K – 7339
2024
Q1 		$85.6K Buy
20,100
+19,900
+9,950% +$83.7K ﹤0.01% 4273
2023
Q4 		$360 Hold
200
– – ﹤0.01% 7122
2023
Q3 		$398 Sell
200
-2,800
-93% -$6.49K ﹤0.01% 7369
2023
Q2 		$7.68K Buy
+3,000
New +$9.52K ﹤0.01% 6523

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's PYXS Position: Q3 2025 in Review

Group One Trading sold out of Pyxis Oncology (PYXS) in Q3 2025, closing a stake of 602 shares — an estimated $867 sold.

Group One Trading first reported a position in PYXS in Q2 2023 and held it in 6 quarters. The position peaked at $7.34K in Q3 2024. 73 funds tracked by Wall St. Rank hold PYXS as of Q3 2025.

  • Group One Trading reported no remaining Pyxis Oncology position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 602 Pyxis Oncology shares in Q3 2025, an estimated $867.
  • Group One Trading first reported a position in Pyxis Oncology in Q2 2023 and held it in 6 quarters.
  • Group One Trading's Pyxis Oncology position peaked at $7.34K in Q3 2024.
  • 73 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.